Table 1. Financial indicators of Peste des Petits Ruminants (PPR) vaccine development and administration to control PPR under actual (1996–97 to 2020–21) and planned future vaccination strategy (100% vaccination for three years [from 2021–22 to 2023–24) and 10% need based/ minimal vaccination coverage for two years (from 2024–25 to 2025–26)] in India.
| Financial indicators | Disease incidence scenarios |
||
|---|---|---|---|
| 10% | 12% | 15% | |
| Total programme cost (USD million) | 386.0 | 386.0 | 386.0 |
| Total benefits/ avoided loss (USD million) | 16,712.6 | 18,840.2 | 22,031.6 |
| Net benefits/ Net returns (NPV) (USD million) | 16,326.6 | 18,454.2 | 21,645.6 |
| IRR (%) | 166.2 | 167.6 | 169.7 |
| B:C ratio | 43.3 | 48.8 | 57.1 |
All the estimates were calculated at 2020-21 prices at 5% discount rate.